Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)

Market Cap	17.30B
Revenue (ttm)	648.05M +24.8%
Net Income	197.00M
EPS	2.83
Shares Out	78.71M
PE Ratio	77.55
Forward PE	79.95
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,400
Average Volume	486,606
Open	213.20
Previous Close	219.80
Day's Range	213.20 - 229.60
52-Week Range	97.50 - 302.40
Beta	n/a
RSI	49.67
Earnings Date	Mar 30, 2026

About HKG:2637

Fujian Haixi Pharmaceuticals Co., Ltd. manufactures and sells pharmaceutical drugs in China. The company offers drugs for oncology, ophthalmology, digestion, cardiovascular, endocrine, and nervous systems, and inflammation. It sells its products through retail pharmacies, online pharmacies, and internet medical platforms. The company was incorporated in 2012 and is based in Fuzhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2012
• Employees: 164
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2637

Financial Performance

In 2025, HKG:2637's revenue was 582.36 million, an increase of 24.79% compared to the previous year's 466.68 million. Earnings were 177.03 million, an increase of 30.09%.

Financial numbers in CNY